SYNH
SYNH Real Time Price USDRecent trades of SYNH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SYNH's directors and management
Government lobbying spending instances
-
$30,000 Oct 18, 2024 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Jul 19, 2024 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Apr 19, 2024 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Jan 19, 2024 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Apr 20, 2023 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 20, 2023 Issue: Government Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Oct 20, 2022 Issue: Government Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jul 20, 2022 Issue: Government Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Jan 20, 2022 Issue: Pharmacy Health Issues Taxation/Internal Revenue Code Medical/Disease Research/Clinical Labs
-
$30,000 Oct 20, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Taxation/Internal Revenue Code Pharmacy
-
$30,000 Jul 20, 2021 Issue: Health Issues Taxation/Internal Revenue Code Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs Health Issues Pharmacy
-
$30,000 Jan 21, 2021 Issue: Health Issues Pharmacy Medical/Disease Research/Clinical Labs
-
$30,000 Oct 20, 2020 Issue: Medical/Disease Research/Clinical Labs Pharmacy Health Issues
-
$30,000 Jul 20, 2020 Issue: Pharmacy Medical/Disease Research/Clinical Labs Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SYNH in WallStreetBets Daily Discussion
Recent insights relating to SYNH
Recent picks made for SYNH stock on CNBC
ETFs with the largest estimated holdings in SYNH
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SYNH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.